Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia

Global surveillance programs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are showing the emergence of variants with mutations in the spike protein. Genomic and laboratory surveillance are important to determine if these variants may be more infectious or less susceptible to anti...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Diego A. Álvarez-Díaz, Ana Luisa Muñoz, Pilar Tavera-Rodríguez, María T. Herrera-Sepúlveda, Hector Alejandro Ruiz-Moreno, Katherine Laiton-Donato, Carlos Franco-Muñoz, Dioselina Pelaez-Carvajal, Diego Cuellar, Alejandra M. Muñoz-Suarez, Marisol Galindo, Edgar J. Arias-Ramírez, Marcela Mercado-Reyes
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2022-01-01
Σειρά:	Vaccines
Θέματα:	COVID-19 spike protein SARS-CoV-2 variants neutralizing antibodies Mu (B.1.621) variant gamma (P.1) variant
Διαθέσιμο Online:	https://www.mdpi.com/2076-393X/10/2/180
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!